title: Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.
abstract: Currently, there is considerable debate regarding the best in vitro method for testing antifungal combinations against Candida spp. In this study, we compared the results obtained by chequerboard dilution, time-kill studies and Etest for several antifungal combinations against Candida spp. Three Candida albicans isolates (fluconazole MICs of 1.0, 32 and >256 mg/L) and three non-albicans Candida isolates (C. glabrata, C. tropicalis and C. krusei) were tested in RPMI 1640 medium. By chequerboard testing, the majority of antifungal combinations were found to be indifferent. Notably, antagonism was identified by time-kill studies and by Etest for combinations of amphotericin B-fluconazole, but it was not detected by the chequerboard method. Pre-exposure of isolates to fluconazole did not affect results of the Etest or chequerboard method, but it did increase the frequency of antagonism noted by time-kill methods. This study indicates that chequerboard dilution testing in RPMI medium may not reliably detect the attenuation of amphotericin B activity. Of the three methods, Etest was the simplest to use and yielded reproducible results for testing antifungal combinations.
authors.affiliation: Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Texas Medical Center, 1441 Moursund Street 423, Houston, TX 77030, USA. rlewis@uh.edu
authors.forename: R E
authors.initials: RE
authors.lastname: Lewis
authors.forename: D J
authors.initials: DJ
authors.lastname: Diekema
authors.forename: S A
authors.initials: SA
authors.lastname: Messer
authors.forename: M A
authors.initials: MA
authors.lastname: Pfaller
authors.forename: M E
authors.initials: ME
authors.lastname: Klepser
mesh_terms: D000666:Amphotericin B / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000935:Antifungal Agents / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000706:statistics & numerical data
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole